Comparative Analysis of Robotic- and Endoscopic-Assisted Minimally Invasive Nipple–Areola Complex–Sparing Mastectomy for Breast Cancer: A Meta-Analysis with Subgroup Analyses
This meta-analysis of twelve studies indicates that robotic and endoscopic nipple-sparing mastectomies offer advantages over conventional open surgery by reducing blood loss, incision size, and postoperative complications, despite requiring longer operative times and lacking sufficient evidence regarding long-term recurrence rates.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Breast cancer surgery has undergone a quiet revolution in recent decades. The goal is no longer just to remove the disease; it is to restore the body with as much care and precision as possible. Central to this shift is a procedure called nipple–areola complex–sparing mastectomy. In this operation, surgeons remove the breast tissue while carefully preserving the skin envelope and the nipple itself, creating a natural foundation for reconstruction. While this approach offers significant psychological and aesthetic benefits, the traditional method of performing it—using a large, open incision—can be invasive. It often requires extensive cutting and lifting of the skin flaps, which can disrupt blood flow to the skin and lead to complications like tissue death or slow healing. These risks can complicate recovery and affect the final appearance, prompting surgeons to look for gentler ways to perform the same life-saving work.
In response to these challenges, a team of researchers from Tsinghua University and Ningxia Medical University set out to examine whether newer, minimally invasive techniques could offer a safer alternative. They focused on two specific methods: robot-assisted surgery, where a surgeon controls mechanical arms with high precision, and endoscopic-assisted surgery, which uses a tiny camera to guide the instruments through small openings. The researchers gathered data from twelve different studies involving thousands of patients to compare these modern approaches against the standard open surgery. Their work was not a single experiment but a synthesis of existing evidence, designed to see if the high-tech methods truly delivered on their promise of less trauma and better outcomes.
The analysis revealed a clear trade-off. The minimally invasive procedures took longer to perform, adding roughly thirty-six minutes to the total time in the operating room. However, this extra time was spent with greater precision, resulting in significantly less blood loss during the surgery. The incisions made for these techniques were also much shorter, measuring about four centimeters compared to nearly nine centimeters for the traditional open method. This reduction in physical trauma translated into tangible benefits for the patients. Those who underwent the minimally invasive surgery experienced fewer overall complications. Specifically, they had lower rates of fluid buildup under the skin, less bleeding or hematoma, and significantly fewer instances of skin necrosis, where the skin tissue dies due to a lack of blood supply.
Perhaps most importantly for the patients' peace of mind, the study found that the safety of the nipple itself was not compromised. The rate of complications affecting the nipple and the surrounding dark circle of skin was statistically similar between the two groups, meaning the delicate structures were preserved just as well with the new techniques as with the old. The researchers also noted that the time required to reconstruct the breast after the removal of tissue was shorter in the minimally invasive group, suggesting that the surgical field was cleaner and more organized when the procedure began. While the data showed a lower rate of cancer recurrence in the minimally invasive group, the researchers cautioned that this finding was based on limited evidence and requires longer-term studies to confirm.
Ultimately, the study suggests that for carefully selected patients, robot and endoscopic-assisted mastectomy offers a compelling balance. It trades a longer time on the table for a shorter recovery, less bleeding, and a lower risk of wound complications. The findings indicate that these advanced tools allow surgeons to remove the cancer with the same oncologic safety as traditional surgery while causing less disruption to the body's natural tissues. As the field of breast cancer care continues to evolve, this evidence supports the idea that high-precision, minimally invasive techniques can be a viable and often superior option, provided the surgical team has the necessary expertise and the patient is a suitable candidate. The path forward, the authors note, lies in conducting more long-term studies to fully understand the durability of these benefits over many years.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.